Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides

Fu-Long Li1,2, Vivian Fu1,2, Guangbo Liu1,2

  • 1Department of Pharmacology, University of California San Diego, La Jolla, CA, USA.

Insights

Microcolin B activates the Hippo pathway, targeting YAP-dependent cancers. This study identifies phosphatidylinositol transfer proteins (PITPα/β) as key regulators, offering new therapeutic avenues for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The Hippo pathway regulates organ size and is crucial for tissue homeostasis.
  • Dysregulation of the Hippo pathway is implicated in cancer development.
  • LATS kinases inhibit YAP/TAZ co-activators, suppressing cell growth.

Purpose of the Study:

  • To identify novel Hippo pathway activators from marine natural products.
  • To elucidate the molecular targets and mechanisms of microcolin B (MCB).
  • To explore the role of identified targets in cancer therapy.

Main Methods:

  • Screening of marine natural products to identify Hippo pathway activators.
  • Structure-activity relationship studies of MCB analogs.
  • Biochemical assays to identify direct molecular targets.
  • Investigation of PITPα/β function in Hippo pathway regulation.

Main Results:

  • Microcolin B (MCB) was identified as a Hippo pathway activator that selectively kills YAP-dependent cancer cells.
  • Structure-activity optimization led to more potent MCB analogs.
  • Phosphatidylinositol transfer proteins α and β (PITPα/β) were identified as direct MCB targets.
  • PITPα/β were found to regulate LATS and YAP activity.
  • PITPα/β influence the Hippo pathway through plasma membrane phosphatidylinositol-4-phosphate.

Conclusions:

  • PITPα/β play a previously unrecognized role in regulating the Hippo pathway.
  • PITPα/β are potential therapeutic targets for cancer treatment.
  • MCB and its analogs represent promising leads for developing novel cancer therapies targeting the Hippo pathway.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K